ADMA BIOLOGICS INC (ADMA)
US0008991046 - Common Stock
| MRQ (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 45.33M | 51.35M | 86.50M | 51.10M | 55.90M | |||
| Marketable Securities | N/A | N/A | N/A | N/A | N/A | |||
| Receivables | 49.62M | 27.42M | 15.50M | 28.60M | 13.20M | |||
| Inventories | 177.73M | 172.91M | 163.30M | 124.70M | 81.50M | |||
| Other Current Assets | 3.74M | 5.33M | 5.10M | 4.30M | 3.00M | |||
| Total Current Assets | 276.42M | 257.01M | 270.40M | 208.70M | 153.70M | |||
| Non-Current Assets | ||||||||
| PPE Net | 64.71M | 63.47M | 68.70M | 58.20M | 45.90M | |||
| Goodwill | 3.53M | 3.53M | 3.50M | 3.50M | 3.50M | |||
| Intangibles | 321.00K | 499.00K | 1.00M | 1.70M | 2.40M | |||
| Other Non-Current Assets | 5.89M | 4.67M | 4.80M | 4.10M | 2.10M | |||
| Total Non-Current Assets | 74.46M | 72.17M | 78.10M | 67.60M | 54.00M | |||
| TOTAL ASSETS | 350.88M | 329.18M | 348.50M | 276.30M | 207.70M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 32.40M | 31.05M | 24.10M | 16.80M | 8.70M | |||
| Accounts Payable | 17.19M | 15.66M | 13.20M | 12.40M | 11.10M | |||
| Other Current Liabilities | 3.50M | 3.09M | 1.90M | 1.20M | 100.00K | |||
| Total Current Liabilities | 53.09M | 49.81M | 39.30M | 30.40M | 19.90M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 130.85M | 130.59M | 142.80M | 94.90M | 93.00M | |||
| Other Non-Current Liabilities | 13.23M | 13.58M | 14.40M | 9.80M | 6.50M | |||
| Total Non-Current Liabilities | 144.08M | 144.17M | 157.20M | 104.70M | 99.50M | |||
| TOTAL LIABILITIES | 197.17M | 193.98M | 196.50M | 135.10M | 119.40M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -488.45M | -506.26M | -478.00M | -412.10M | -340.50M | |||
| Additional Paid In Capital | 642.13M | 641.44M | 630.00M | 553.30M | 428.70M | |||
| Common Shares | 23.00K | 23.00K | 0.00 | 0.00 | 0.00 | |||
| Shares Outstanding | 231.77M | 226.06M | 221.80M | 195.80M | 104.90M | |||
| Tangible Book Value per Share | 0.65 | 0.58 | 0.67 | 0.69 | 0.78 | |||
| Total Shareholders' Equity | 153.71M | 135.21M | 152.00M | 141.20M | 88.20M | |||
| TOTAL LIABILITIES AND EQUITY | 350.88M | 329.18M | 348.50M | 276.30M | 207.70M | |||
| Statistics | ||||||||
| Debt/Equity | 0.85 | 0.97 | 0.94 | 0.67 | 1.05 | |||
| Current Ratio | 5.21 | 5.16 | 6.88 | 6.87 | 7.72 | |||
| Return On Assets (ROA) | -1.04% | -8.58% | -18.91% | -25.91% | -36.45% | |||
| Return On Equity (ROE) | -2.37% | -20.89% | -43.36% | -50.71% | -85.83% | |||
| Return On Invested Capital (ROIC) | 11.75% | 6.12% | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | 13.85% | 7.49% | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | 14.07% | 7.63% | N/A | N/A | N/A | |||
All data in USD